San Francisco, Calif. June 7, 2004 The economics and traditional structure of drug development are shifting in ways that could lead to viable markets for new, affordable drugs in the developing world if biopharmaceutical companies considered innovative collaborations with nonprofits, according to Victoria Hale, Ph.D., founder and CEO of the Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S.
Dr. Hale will speak at the BIO 2004 Annual International Convention in San Francisco as part of the Global Health track in a panel session titled "Mutually Inclusive: New and Affordable Drugs for Developed, Developing Worlds." The session will take place today, June 7, at 2:15 pm in the Moscone Convention Center, Room #2007 West.
Dr. Hale will speak about her company's proven record of collaboration that enables drug companies to partner without compromising their profitability goals. "The benefits of such collaborations are vast," stated Dr. Hale. "By working with us and other like-minded nonprofits, industry is an active partner in bringing new, affordable drugs to cure infectious diseases in the developing world, and helps to nurture new markets."
New advances in biotechnology manufacturing, splitting of intellectual property between partners to cover various geographies and indications, donations of promising but unused intellectual property, and sharing investments and risks in drug development are some of the strategies OneWorld Health uses to create collaborations with industry.
The most vital resource needed to achieve successful collaborations is people -- professionals with biopharmaceutical expertise. Dr. Hale said OneWorld Health will seek out companies that offer executive loan or sabbatical programs that would allow their employees to lend their talents to the nonprofit pharmaceutical company in specific programs.
The panel consists of:Page: 1 2 Related biology news :1
Chair: Tom Brewer, Senior Project Offic
Contact: Joanne Hasegawa
Institute for OneWorld Health
. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions2
. Institute for OneWorld Health nominated for the 2004 World Technology Awards3
. Institute for OneWorld Health receives Gates Foundation grant4
. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health5
. OneWorld Health completes enrollment, treatment in Phase III India trial6
. Institute for OneWorld Health CEO advocates focus first on developing world markets7
. OneWorld Health plans to form network of volunteer pharmaceutical scientists for global health8
. UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment9
. Victoria Hale of Institute for OneWorld Health Named Fellow by International Womens Forum10
. Health of worlds sea lions the focus of Wakefield Symposium11
. Healthy fats and oils essential to satisfy calorie-conscious consumers